Bolt Biotherapeutics, Inc.
BOLT
$5.32
$0.050.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.91M | 34.77M | 38.84M | 47.32M | 53.80M |
| Total Receivables | 948.00K | 100.00K | 710.00K | 807.50K | 425.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.96M | 2.68M | 2.18M | 1.84M | 2.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 784.00K | 784.00K | 784.00K | 839.00K | 792.00K |
| Total Current Assets | 35.61M | 38.34M | 42.51M | 50.81M | 57.15M |
|
|
|||||
| Total Current Assets | 35.61M | 38.34M | 42.51M | 50.81M | 57.15M |
| Net Property, Plant & Equipment | 21.38M | 22.24M | 23.21M | 24.90M | 20.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.16M | 1.20M | 1.03M | 1.04M | 1.27M |
| Total Assets | 65.05M | 75.50M | 85.86M | 99.63M | 109.33M |
|
|
|||||
| Total Accounts Payable | 1.52M | 1.85M | 1.53M | 1.51M | 1.48M |
| Total Accrued Expenses | 3.84M | 5.35M | 6.25M | 8.34M | 10.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.70M | 2.56M | 2.40M | 2.25M | 2.82M |
| Total Finance Division Other Current Liabilities | 1.91M | 2.55M | 3.38M | 3.75M | 3.35M |
| Total Other Current Liabilities | 1.91M | 2.55M | 3.38M | 3.75M | 3.35M |
| Total Current Liabilities | 9.97M | 12.31M | 13.56M | 15.86M | 18.08M |
|
|
|||||
| Total Current Liabilities | 9.97M | 12.31M | 13.56M | 15.86M | 18.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.89M | 21.62M | 22.31M | 22.96M | 15.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.10M | 2.72M | 3.18M | 3.62M | 3.87M |
| Total Liabilities | 32.95M | 36.66M | 39.05M | 42.43M | 37.30M |
|
|
|||||
| Common Stock & APIC | 486.26M | 485.85M | 485.21M | 484.50M | 483.29M |
| Retained Earnings | -454.15M | -447.00M | -438.44M | -427.40M | -411.47M |
| Treasury Stock & Other | -10.00K | -6.00K | 40.00K | 97.00K | 205.00K |
| Total Common Equity | 32.10M | 38.84M | 46.81M | 57.20M | 72.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.10M | 38.84M | 46.81M | 57.20M | 72.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.10M | 38.84M | 46.81M | 57.20M | 72.03M |
|
|
|||||